TY - JOUR
T1 - Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse
AU - Warden, Diane
AU - Trivedi, Madhukar H.
AU - Greer, Tracy L.
AU - Nunes, Edward
AU - Grannemann, Bruce D.
AU - Horigian, Viviana E.
AU - Somoza, Eugene
AU - Ring, Kolette
AU - Kyle, Tiffany
AU - Szapocznik, José
N1 - Funding Information:
Edward Nunes, M.D. has received funding from NIDA for grants K24DA022412 (PI: Nunes) and U10DA13035 (PI: Nunes).
Funding Information:
This work is supported by the National Institute on Drug Abuse through the Clinical Trials Network for the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) study, Madhukar H. Trivedi, M.D., Lead Investigator ( U10DA020024 ).
Funding Information:
Diane Warden, Ph.D., M.B.A. has owned stock in Bristol Myers Squibb and Pfizer, Inc. in the last 5 years and has received funding from the National Alliance for Research in Schizophrenia and Depression.
PY - 2012/1
Y1 - 2012/1
N2 - Although the selection of appropriate clinical sites has a significant impact on the successful conduct of clinical trials, no generally accepted model is available for site selection. Use of an appropriate site selection process is even more pertinent when conducting large scale, practical clinical trials in practice settings.This report provides a rationale for selecting sites by identifying both a set of basic site selection criteria important to most trials as well as criteria specific to the features of a particular study's design. In this two-tier system, although all these criteria must be met, some criteria are firm and viewed as essential for a site to conduct the trial. Other criteria, such as those that support study recruitment or participant retention, are flexible. These flexible criteria may be addressed through several alternative solutions that meet the original intent of the criterion.We illustrate how the study specific features and requirements of Stimulant Reduction Intervention using Dosed Exercise (STRIDE), a multisite clinical trial evaluating the efficacy of exercise or health education, added to treatment as usual for stimulant abuse are linked to firm and flexible site selection criteria. We also present an iterative, multi-step approach to site selection including building awareness about the study and screening and evaluating sites using these criteria.This simple model could maximize the chance that selected sites will implement a study successfully and achieve trial aims. It may be helpful to researchers who are developing criteria and methods for site selection for specific clinical trials.
AB - Although the selection of appropriate clinical sites has a significant impact on the successful conduct of clinical trials, no generally accepted model is available for site selection. Use of an appropriate site selection process is even more pertinent when conducting large scale, practical clinical trials in practice settings.This report provides a rationale for selecting sites by identifying both a set of basic site selection criteria important to most trials as well as criteria specific to the features of a particular study's design. In this two-tier system, although all these criteria must be met, some criteria are firm and viewed as essential for a site to conduct the trial. Other criteria, such as those that support study recruitment or participant retention, are flexible. These flexible criteria may be addressed through several alternative solutions that meet the original intent of the criterion.We illustrate how the study specific features and requirements of Stimulant Reduction Intervention using Dosed Exercise (STRIDE), a multisite clinical trial evaluating the efficacy of exercise or health education, added to treatment as usual for stimulant abuse are linked to firm and flexible site selection criteria. We also present an iterative, multi-step approach to site selection including building awareness about the study and screening and evaluating sites using these criteria.This simple model could maximize the chance that selected sites will implement a study successfully and achieve trial aims. It may be helpful to researchers who are developing criteria and methods for site selection for specific clinical trials.
KW - Clinical trials
KW - Effectiveness
KW - Efficacy
KW - Exercise
KW - Site selection
KW - Substance use
UR - http://www.scopus.com/inward/record.url?scp=84855355715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855355715&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2011.08.011
DO - 10.1016/j.cct.2011.08.011
M3 - Article
C2 - 21946515
AN - SCOPUS:84855355715
SN - 1551-7144
VL - 33
SP - 29
EP - 37
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
IS - 1
ER -